Profil de l'entreprise pour EUCRATES BIOMEDICAL ACQUISITION CORP - UNIT Action
Eucrates Biomedical Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses to identify and acquire a business in the biomedical or healthcare-related industries in North America and Europe. The company was incorporated in 2020 and is based in New York, New York.
Analyse IA de EUCRATES BIOMEDICAL ACQUISITION CORP - UNIT
Cliquez sur l’une des analyses ci-dessous pour obtenir des informations instantanées de l’IA via finAgent
Neuste KI Analysen zu EUCRATES BIOMEDICAL ACQUISITION CORP - UNIT
Für dieses Unternehmen sind noch keine KI-Threads verfügbar.
Unternehmensdaten
NameEUCRATES BIOMEDICAL ACQUISITION CORP - UNIT
FirmaEucrates Biomedical Acquisition Corp.
SymbolEUCRU
Heimatbörse
NASDAQ
ISINVGG3141W1142
WertpapierartAktie
SektorFinancial Services
BrancheShell Companies
CEOParag Phoolchand Saxena MBA, MS
Marktkapitalisierung47 Mio
LandVereinigte Staaten von Amerika
WährungUSD
Mitarbeiter-
Adresse250 West 55th Street, 10019 New York City
IPO Datum2020-10-06
Ticker Symbole
Name
Symbol
NASDAQ
EUCRU
Weitere Aktien
Investoren, die EUCRATES BIOMEDICAL ACQUISITION CORP - UNIT halten, haben auch folgende Aktien im Depot: